Fujian Cosunter Pharmaceutical Co., Ltd. (SZSE: 300436)
Health Care · Pharmaceuticals · CN
CN¥83.68
-1.18% today · -11.9% 1Y
Fujian Cosunter Pharmaceutical Co., Ltd. (SZSE: 300436) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.10B and employs 715 people.
Over the last twelve months the share price has lost 11.9%, trading between 79.00 and 149.00.
Tweenvest scores Fujian Cosunter Pharmaceutical Co., Ltd. across four factors: quality 55/100, value 55/100, growth 26/100. Its strongest factor is quality.
300436 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.10B
- Revenue (TTM)
- $62.96M
- P/E
- —
- EPS
- -1.38
- Dividend yield
- —
- Beta (5Y)
- 1.17
- 52-week high
- CN¥149.00
- 52-week low
- CN¥79.00
- Avg volume (3M)
- —
- Shares outstanding
- 168.03M
- Employees
- 715
- Next earnings
- —
About Fujian Cosunter Pharmaceutical Co., Ltd.
Established in 2001 and headquartered in Fuzhou, China, Fujian Cosunter Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the pharmaceutical industry. The company is actively involved in the full spectrum of pharmaceutical operations, encompassing the research and development, production, and sale of medicinal products across China. Its core offerings comprise Chinese patent medicines, which are utilized in treating a variety of conditions, including liver ailments, men's health (andrology), cardiovascular disorders, and other therapeutic areas.
- ISIN
- CNE100001YZ0
- Founded
- 2001
- Listed since
- May 4, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | $2.12B | CN¥22.60 | +0.31% |
| Dermapharm Holding SEXTRA: DMP | $2.12B | €38.15 | -1.93% |
| Grand Pharmaceutical Group LimitedSEHK: 512 | $2.11B | HK$4.74 | -1.76% |
| Granules India LimitedBSE: 532482 | $2.11B | Rs820.80 | -5.80% |
| Guobang Pharma Ltd.SHSE: 605507 | $2.08B | CN¥18.09 | -0.06% |
| Caplin Point Laboratories LimitedBSE: 524742 | $2.08B | Rs2,632.35 | -7.17% |
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | $2.03B | CN¥11.75 | +2.80% |
| Perrigo Company plcNYSE: PRGO | $2.01B | $14.50 | -0.34% |
Figures last refreshed Oct 4, 2026.